Tuoping Luo

Tuoping Luo

Auto-generated profile, based on publicly available information

Tuoping Luo

Peking University

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 April 2020 in Cell Research
Verified
Journal Article
Open access
PDF file
YCYusheng Cai
Yusheng Cai
HZHuanhuan Zhou
Huanhuan Zhou
YZYinhua Zhu
Yinhua Zhu
QSQi Sun
Qi Sun
YJYin Ji
Yin Ji
HDHongkui Deng
Hongkui Deng
Cellular senescence, a persistent state of cell cycle arrest, accumulates in aged organisms, contributes to tissue dysfunction, and drives age-related phenotypes. The clearance of senescent cells is expected to decrease chronic, low-grade inflammation and improve tissue repair capacity, thus attenuating the decline of physical function in aged organisms. However, selective and effective clearance of senescent cells of different cell types has proven challenging. Herein, we developed a prodrug strategy to design a new compound based on the increased activity of lysosomal β-galactosidase (β-gal), a primary characteristic of senescent cells. Our prodrug SSK1 is specifically activated by β-gal and eliminates mouse and human senescent cells independently of senescence inducers and cell types. In aged mice, our compound effectively cleared senescent cells in different tissues, decreased the senescence- and age-associated gene signatures, attenuated low-grade local and systemic inflammation, and restored physical function. Our results demonstrate that lysosomal β-gal can be effectively leveraged to selectively eliminate senescent cells, providing a novel strategy to develop anti-aging interventions.

22 April 2020 in ACS Central Science
Verified
Journal Article
Open access
BHBenke Hong
Benke Hong
TLTuoping Luo
Tuoping Luo
XLXiaoguang Lei
Xiaoguang Lei
Late-stage diversification of natural products is an efficient way to generate natural product derivatives for drug discovery and chemical biology. Benefiting from the development of site-selective synthetic methodologies, late-stage diversification of natural products has achieved notable success. This outlook will outline selected examples of novel methodologies for site-selective transformations of reactive functional groups and inert C–H bonds that enable late-stage diversification of complex natural products. Accordingly, late-stage diversification provides an opportunity to rapidly access various derivatives for modifying lead compounds, identifying cellular targets, probing protein–protein interactions, and elucidating natural product biosynthetic relationships.

11 June 2018 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
JDJianye Dai
Jianye Dai
KLKai Liang
Kai Liang
SZShan Zhao
Shan Zhao
WJWentong Jia
Wentong Jia
YLYuan Liu
Yuan Liu
CWChu Wang
Chu Wang
Significance: Baicalin is a major flavonoid component from the herbal medicine Scutellaria baicalensis that has been shown to have an antisteatosis effect. Through quantitative chemoproteomic profiling, we discovered that baicalin acts as a natural allosteric activator of carnitine palmitoyltransferase 1 (CPT1), the rate-limiting enzyme of fatty acid β-oxidation (FAO). By directly binding to CPT1 and activating its activity to accelerate fatty acid degradation, baicalin can significantly ameliorate symptoms associated with hepatic steatosis and reduce diet-induced obesity (DIO). Our study provides an example of a natural product agonist for CPT1. The results provide mechanistic insights to explain the bioactivity of baicalin in reducing lipid accumulation and introduce exciting opportunities for developing novel flavonoid-based FAO activators for pharmacologically treating DIO and associated metabolic disorders.

30 January 2014 in Natural Product Reports
Verified
Journal Article
Closed access
PDF file
YZYun Zhang
Yun Zhang
TLTuoping Luo
Tuoping Luo
ZYZhen Yang
Zhen Yang
This review has been organized from the perspective of synthetic target families, with emphasis on the use of gold-catalyzed transformations and cascade reactions that significantly increase molecular complexity.

18 May 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
CGChengcheng Guan
Chengcheng Guan
YNYange Niu
Yange Niu
SCSi-Cong Chen
Si-Cong Chen
YKYunlu Kang
Yunlu Kang
JWJing-Xiang Wu
Jing-Xiang Wu
LCLei Chen
Lei Chen
Sterol O-acyltransferase 1 (SOAT1) is an endoplasmic reticulum (ER) resident, multi-transmembrane enzyme that belongs to the membrane-bound O-acyltransferase (MBOAT) family. It catalyzes the esterification of cholesterol to generate cholesteryl esters for cholesterol storage. SOAT1 is a target to treat several human diseases. However, its structure and mechanism remain elusive since its discovery. Here, we report the structure of human SOAT1 (hSOAT1) determined by cryo-EM. hSOAT1 is a tetramer consisted of a dimer of dimer. The structure of hSOAT1 dimer at 3.5 Å resolution reveals that a small molecule inhibitor CI-976 binds inside the catalytic chamber and blocks the accessibility of the active site residues H460, N421 and W420. Our results pave the way for future mechanistic study and rational drug design targeting hSOAT1 and other mammalian MBOAT family members.

2 March 2016 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
SZShan Zhao
Shan Zhao
JDJianye Dai
Jianye Dai
MHMo Hu
Mo Hu
CLChang Liu
Chang Liu
RMRong Meng
Rong Meng
TLTuoping Luo
Tuoping Luo
The coupling reactions of diaryltetrazoles with carboxylic acids under UV irradiation were investigated. Application of these transformations in chemical biology was demonstrated in photo-labelling the proteinogenic carboxylic acids in purified proteins, cell lysates and living cells.